Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways

Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways

<p>Figure S2. Lurbinectedin sensitivity (IC50) correlation with MYC expression and changes in expression of NE markers.</p>

Збережено в:
Бібліографічні деталі
Автор: Subhamoy Chakraborty (16648124) (author)
Інші автори: Charles Coleman (16648127) (author), Parvathy Manoj (16648130) (author), Deniz Demircioglu (15306139) (author), Nisargbhai Shah (16648133) (author), Elisa de Stanchina (14954757) (author), Charles M. Rudin (11572933) (author), Dan Hasson (15306151) (author), Triparna Sen (14126577) (author)
Опубліковано: 2025
Предмети:
Cancer
Cancer Detection and Diagnosis
Methods and Technology
Biomarkers
Lung Cancer
Preclinical Models
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси